Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
PureTech Health plc
0VQ0Current price
19.8 EUR
0 EUR (0.00%)
Last closed
166 GBX
Company
www.puretechhealth.com
ISIN
GB00BY2Z0H74
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
397 306 307 GBX
Yield for 12 month
+18.87 %
1Y
3Y
5Y
10Y
15Y
0VQ0
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. It also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; SPT-320, a novel prodrug of agomelatine for the treatment of generalized anxiety disorder; and SPT-348, a prodrug of a non-hallucinogenic neuroplastogen for the treatment of mood and other neuropsychiatric disorders. In addition, the company is developing hydrogels to enable the oral administration of peptide therapeutics in preclinical development. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. Address: 6 Tide Street, Boston, MA, United States, 02210
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
42 843.97 GBXP/E ratio
–Dividend Yield
–Current Year
+58 707 525 GBX
Last Year
+163 598 303 GBX
Current Quarter
+11 271 845 GBX
Last Quarter
+11 271 845 GBX
Current Year
-7 474 250 700 GBX
Last Year
-11 768 353 908 GBX
Current Quarter
-1 512 305 844 GBX
Last Quarter
-1 512 305 844 GBX
Key Figures 0VQ0
1 year
3 years
5 years
10 years
EBITDA
-133 557 662 GBX
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-13.39 %
PEG Ratio
–
Return On Equity TTM
-22.07 %
Wall Street Target Price
42 843.97 GBX
Revenue TTM
463 931 GBX
Book Value
1.31 GBX
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-90.9 %
Dividend Yield
–
Gross Profit TTM
17 236 830 GBX
Earnings per share
-0.24 GBX
Diluted Eps TTM
-0.24 GBX
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
61.5 %
Profit Margin
–
Dividend Analytics 0VQ0
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 0VQ0
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 0VQ0
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
348.8244
Price Sales TTM
856.3904
Enterprise Value EBITDA
-9.3016
Price Book MRQ
1.605
Financials 0VQ0
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 0VQ0
For 52 weeks
137.54 GBX
236.43 GBX
50 Day MA
155.21 GBX
Shares Short Prior Month
–
200 Day MA
183.98 GBX
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart